Global Monoclonal Antibodies Market Research Report 2023

Publisher Name :
Date: 07-Feb-2023
No. of pages: 91
Inquire Before Buying

Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.

Highlights

The global Monoclonal Antibodies market was valued at US$ 105790 million in 2022 and is anticipated to reach US$ 144360 million by 2029, witnessing a CAGR of 4.5% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies.

The Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Biocon

- Celltrion

- Dr. Reddy's Laboratories

- Hospira

- 3SBio

- Accord Healthcare

- AET Biotech

- Allergan

- Amega Biotech

Segment by Type

- Erythropoietin (EPO)

- Human Growth Hormone (HGH)

- Granulocyte- Colony Stimulating Factor (G-CSF)

- Monoclonal Antibody (mAb)

- Insulin

- Interferon (IFN)

- Others

Segment by Application

- Anti-Cancer

- Anti-Inflammatory/Autoimmune

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Monoclonal Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Monoclonal Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Monoclonal Antibodies Market Research Report 2023

Table of Contents
1 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of Monoclonal Antibodies
1.2 Monoclonal Antibodies Segment by Type
1.2.1 Global Monoclonal Antibodies Market Value Comparison by Type (2023-2029)
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Monoclonal Antibodies Segment by Application
1.3.1 Global Monoclonal Antibodies Market Value by Application: (2023-2029)
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Global Monoclonal Antibodies Market Size Estimates and Forecasts
1.4.1 Global Monoclonal Antibodies Revenue 2018-2029
1.4.2 Global Monoclonal Antibodies Sales 2018-2029
1.4.3 Global Monoclonal Antibodies Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Monoclonal Antibodies Market Competition by Manufacturers
2.1 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2018-2023)
2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2018-2023)
2.4 Global Monoclonal Antibodies Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monoclonal Antibodies, Product Type & Application
2.7 Monoclonal Antibodies Market Competitive Situation and Trends
2.7.1 Monoclonal Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monoclonal Antibodies Players Market Share by Revenue
2.7.3 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monoclonal Antibodies Retrospective Market Scenario by Region
3.1 Global Monoclonal Antibodies Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Monoclonal Antibodies Global Monoclonal Antibodies Sales by Region: 2018-2029
3.2.1 Global Monoclonal Antibodies Sales by Region: 2018-2023
3.2.2 Global Monoclonal Antibodies Sales by Region: 2024-2029
3.3 Global Monoclonal Antibodies Global Monoclonal Antibodies Revenue by Region: 2018-2029
3.3.1 Global Monoclonal Antibodies Revenue by Region: 2018-2023
3.3.2 Global Monoclonal Antibodies Revenue by Region: 2024-2029
3.4 North America Monoclonal Antibodies Market Facts & Figures by Country
3.4.1 North America Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Monoclonal Antibodies Sales by Country (2018-2029)
3.4.3 North America Monoclonal Antibodies Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Monoclonal Antibodies Market Facts & Figures by Country
3.5.1 Europe Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Monoclonal Antibodies Sales by Country (2018-2029)
3.5.3 Europe Monoclonal Antibodies Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Monoclonal Antibodies Sales by Country (2018-2029)
3.6.3 Asia Pacific Monoclonal Antibodies Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Monoclonal Antibodies Market Facts & Figures by Country
3.7.1 Latin America Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Monoclonal Antibodies Sales by Country (2018-2029)
3.7.3 Latin America Monoclonal Antibodies Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Monoclonal Antibodies Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Monoclonal Antibodies Sales by Country (2018-2029)
3.8.3 Middle East and Africa Monoclonal Antibodies Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Monoclonal Antibodies Sales by Type (2018-2029)
4.1.1 Global Monoclonal Antibodies Sales by Type (2018-2023)
4.1.2 Global Monoclonal Antibodies Sales by Type (2024-2029)
4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2018-2029)
4.2 Global Monoclonal Antibodies Revenue by Type (2018-2029)
4.2.1 Global Monoclonal Antibodies Revenue by Type (2018-2023)
4.2.2 Global Monoclonal Antibodies Revenue by Type (2024-2029)
4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2018-2029)
4.3 Global Monoclonal Antibodies Price by Type (2018-2029)
5 Segment by Application
5.1 Global Monoclonal Antibodies Sales by Application (2018-2029)
5.1.1 Global Monoclonal Antibodies Sales by Application (2018-2023)
5.1.2 Global Monoclonal Antibodies Sales by Application (2024-2029)
5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2018-2029)
5.2 Global Monoclonal Antibodies Revenue by Application (2018-2029)
5.2.1 Global Monoclonal Antibodies Revenue by Application (2018-2023)
5.2.2 Global Monoclonal Antibodies Revenue by Application (2024-2029)
5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2018-2029)
5.3 Global Monoclonal Antibodies Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Biocon
6.1.1 Biocon Corporation Information
6.1.2 Biocon Description and Business Overview
6.1.3 Biocon Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Biocon Monoclonal Antibodies Product Portfolio
6.1.5 Biocon Recent Developments/Updates
6.2 Celltrion
6.2.1 Celltrion Corporation Information
6.2.2 Celltrion Description and Business Overview
6.2.3 Celltrion Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Celltrion Monoclonal Antibodies Product Portfolio
6.2.5 Celltrion Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Hospira
6.4.1 Hospira Corporation Information
6.4.2 Hospira Description and Business Overview
6.4.3 Hospira Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hospira Monoclonal Antibodies Product Portfolio
6.4.5 Hospira Recent Developments/Updates
6.5 3SBio
6.5.1 3SBio Corporation Information
6.5.2 3SBio Description and Business Overview
6.5.3 3SBio Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.5.4 3SBio Monoclonal Antibodies Product Portfolio
6.5.5 3SBio Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Accord Healthcare Monoclonal Antibodies Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 AET Biotech
6.6.1 AET Biotech Corporation Information
6.6.2 AET Biotech Description and Business Overview
6.6.3 AET Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AET Biotech Monoclonal Antibodies Product Portfolio
6.7.5 AET Biotech Recent Developments/Updates
6.8 Allergan
6.8.1 Allergan Corporation Information
6.8.2 Allergan Description and Business Overview
6.8.3 Allergan Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Allergan Monoclonal Antibodies Product Portfolio
6.8.5 Allergan Recent Developments/Updates
6.9 Amega Biotech
6.9.1 Amega Biotech Corporation Information
6.9.2 Amega Biotech Description and Business Overview
6.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amega Biotech Monoclonal Antibodies Product Portfolio
6.9.5 Amega Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monoclonal Antibodies Industry Chain Analysis
7.2 Monoclonal Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monoclonal Antibodies Production Mode & Process
7.4 Monoclonal Antibodies Sales and Marketing
7.4.1 Monoclonal Antibodies Sales Channels
7.4.2 Monoclonal Antibodies Distributors
7.5 Monoclonal Antibodies Customers
8 Monoclonal Antibodies Market Dynamics
8.1 Monoclonal Antibodies Industry Trends
8.2 Monoclonal Antibodies Market Drivers
8.3 Monoclonal Antibodies Market Challenges
8.4 Monoclonal Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibodies Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Monoclonal Antibodies Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2022
Table 4. Global Monoclonal Antibodies Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Monoclonal Antibodies Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Monoclonal Antibodies Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Monoclonal Antibodies Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Monoclonal Antibodies, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Monoclonal Antibodies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Monoclonal Antibodies, Product Type & Application
Table 12. Global Key Manufacturers of Monoclonal Antibodies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Monoclonal Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Monoclonal Antibodies Sales by Region (2018-2023) & (Units)
Table 18. Global Monoclonal Antibodies Sales Market Share by Region (2018-2023)
Table 19. Global Monoclonal Antibodies Sales by Region (2024-2029) & (Units)
Table 20. Global Monoclonal Antibodies Sales Market Share by Region (2024-2029)
Table 21. Global Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Monoclonal Antibodies Revenue Market Share by Region (2018-2023)
Table 23. Global Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Monoclonal Antibodies Revenue Market Share by Region (2024-2029)
Table 25. North America Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 27. North America Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 28. North America Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 32. Europe Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 33. Europe Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Monoclonal Antibodies Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Monoclonal Antibodies Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Monoclonal Antibodies Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Monoclonal Antibodies Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Monoclonal Antibodies Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 42. Latin America Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 43. Latin America Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Monoclonal Antibodies Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Monoclonal Antibodies Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Monoclonal Antibodies Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Monoclonal Antibodies Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Monoclonal Antibodies Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Monoclonal Antibodies Sales (Units) by Type (2018-2023)
Table 51. Global Monoclonal Antibodies Sales (Units) by Type (2024-2029)
Table 52. Global Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 53. Global Monoclonal Antibodies Sales Market Share by Type (2024-2029)
Table 54. Global Monoclonal Antibodies Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Monoclonal Antibodies Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Monoclonal Antibodies Revenue Market Share by Type (2018-2023)
Table 57. Global Monoclonal Antibodies Revenue Market Share by Type (2024-2029)
Table 58. Global Monoclonal Antibodies Price (USD/Unit) by Type (2018-2023)
Table 59. Global Monoclonal Antibodies Price (USD/Unit) by Type (2024-2029)
Table 60. Global Monoclonal Antibodies Sales (Units) by Application (2018-2023)
Table 61. Global Monoclonal Antibodies Sales (Units) by Application (2024-2029)
Table 62. Global Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 63. Global Monoclonal Antibodies Sales Market Share by Application (2024-2029)
Table 64. Global Monoclonal Antibodies Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Monoclonal Antibodies Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Monoclonal Antibodies Revenue Market Share by Application (2018-2023)
Table 67. Global Monoclonal Antibodies Revenue Market Share by Application (2024-2029)
Table 68. Global Monoclonal Antibodies Price (USD/Unit) by Application (2018-2023)
Table 69. Global Monoclonal Antibodies Price (USD/Unit) by Application (2024-2029)
Table 70. Biocon Corporation Information
Table 71. Biocon Description and Business Overview
Table 72. Biocon Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Biocon Monoclonal Antibodies Product
Table 74. Biocon Recent Developments/Updates
Table 75. Celltrion Corporation Information
Table 76. Celltrion Description and Business Overview
Table 77. Celltrion Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Celltrion Monoclonal Antibodies Product
Table 79. Celltrion Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Corporation Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Dr. Reddy's Laboratories Monoclonal Antibodies Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Hospira Corporation Information
Table 86. Hospira Description and Business Overview
Table 87. Hospira Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Hospira Monoclonal Antibodies Product
Table 89. Hospira Recent Developments/Updates
Table 90. 3SBio Corporation Information
Table 91. 3SBio Description and Business Overview
Table 92. 3SBio Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. 3SBio Monoclonal Antibodies Product
Table 94. 3SBio Recent Developments/Updates
Table 95. Accord Healthcare Corporation Information
Table 96. Accord Healthcare Description and Business Overview
Table 97. Accord Healthcare Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Accord Healthcare Monoclonal Antibodies Product
Table 99. Accord Healthcare Recent Developments/Updates
Table 100. AET Biotech Corporation Information
Table 101. AET Biotech Description and Business Overview
Table 102. AET Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. AET Biotech Monoclonal Antibodies Product
Table 104. AET Biotech Recent Developments/Updates
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Business Overview
Table 107. Allergan Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Allergan Monoclonal Antibodies Product
Table 109. Allergan Recent Developments/Updates
Table 110. Amega Biotech Corporation Information
Table 111. Amega Biotech Description and Business Overview
Table 112. Amega Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Amega Biotech Monoclonal Antibodies Product
Table 114. Amega Biotech Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Monoclonal Antibodies Distributors List
Table 118. Monoclonal Antibodies Customers List
Table 119. Monoclonal Antibodies Market Trends
Table 120. Monoclonal Antibodies Market Drivers
Table 121. Monoclonal Antibodies Market Challenges
Table 122. Monoclonal Antibodies Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Monoclonal Antibodies
Figure 2. Global Monoclonal Antibodies Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Monoclonal Antibodies Market Share by Type in 2022 & 2029
Figure 4. Erythropoietin (EPO) Product Picture
Figure 5. Human Growth Hormone (HGH) Product Picture
Figure 6. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Figure 7. Monoclonal Antibody (mAb) Product Picture
Figure 8. Insulin Product Picture
Figure 9. Interferon (IFN) Product Picture
Figure 10. Others Product Picture
Figure 11. Global Monoclonal Antibodies Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Monoclonal Antibodies Market Share by Application in 2022 & 2029
Figure 13. Anti-Cancer
Figure 14. Anti-Inflammatory/Autoimmune
Figure 15. Global Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Monoclonal Antibodies Market Size (2018-2029) & (US$ Million)
Figure 17. Global Monoclonal Antibodies Sales (2018-2029) & (Units)
Figure 18. Global Monoclonal Antibodies Average Price (USD/Unit) & (2018-2029)
Figure 19. Monoclonal Antibodies Report Years Considered
Figure 20. Monoclonal Antibodies Sales Share by Manufacturers in 2022
Figure 21. Global Monoclonal Antibodies Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Monoclonal Antibodies Players: Market Share by Revenue in 2022
Figure 23. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Monoclonal Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 26. North America Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 30. Europe Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 31. Germany Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Monoclonal Antibodies Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Monoclonal Antibodies Revenue Market Share by Region (2018-2029)
Figure 38. China Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Taiwan Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Philippines Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 49. Latin America Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibodies Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. U.A.E Monoclonal Antibodies Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Monoclonal Antibodies by Type (2018-2029)
Figure 59. Global Revenue Market Share of Monoclonal Antibodies by Type (2018-2029)
Figure 60. Global Monoclonal Antibodies Price (USD/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Monoclonal Antibodies by Application (2018-2029)
Figure 62. Global Revenue Market Share of Monoclonal Antibodies by Application (2018-2029)
Figure 63. Global Monoclonal Antibodies Price (USD/Unit) by Application (2018-2029)
Figure 64. Monoclonal Antibodies Value Chain
Figure 65. Monoclonal Antibodies Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs